Fig. 4From: Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancerOverall survival of patients. Kaplan-Meier analysis of the survival of patients with and without MLL2 (n = 194; 17 MLL2 mt and 177 MLL2 wt patients) (a), or ERBB2 (n = 194; 10 ERBB2 mt and 184 ERBB2 wt patients) (b) mutations. Differences were evaluated by the Log-rank (Mantel-Cox) test. mt, mutant; wt, wild-typeBack to article page